| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |